BACKGROUND: Infectious diarrhea is a common problem among travelers. Expert guidelines recommend the prompt use of antibiotics for self-treatment of moderate or severe travelers' diarrhea (TD). There is limited data on whether travelers follow these self-treatment guidelines. We evaluated the risk factors associated with TD, the use of TD self-treatment, and the risk of irritable bowel syndrome (IBS) during travel. METHODS: Department of Defense beneficiaries traveling outside the United States for ≤6.5 months were enrolled in a prospective cohort study. Participants received pre- and post-travel surveys, and could opt into a travel illness diary and follow-up surveys for symptoms of IBS. Standard definitions were used to assess for TD and IBS. Suboptimal self-treatment was defined as the use of antibiotics (with or without antidiarrheal agents) for mild TD, or the use of antidiarrheals alone or no self-treatment in cases of moderate or severe TD. RESULTS: Twenty-four percent of participants (270/1,120) met the criteria for TD. The highest incidence was recorded in Africa [8.6 cases/100 person-weeks, 95% confidence interval (CI): 6.7-10.5]. Two hundred and twelve participants with TD provided information regarding severity and self-treatment: 89 (42%) had mild TD and 123 (58%) had moderate or severe TD. Moderate or severe TD was independently associated with suboptimal self-treatment [OR 10.4 (95% CI: 4.92-22.0)]. Time to last unformed stool did not differ between optimal and suboptimal self-treatment. IBS occurred in 4.5% (7/154) of TD cases and in 3.1% (16/516) of cases without TD (p = 0.39). Among TD cases, a lower incidence of IBS was noted in participants who took antibiotics [4.8% (5/105) vs 2.2% (1/46)] in those who did not, but the difference did not reach statistical significance (p = 0.60). CONCLUSIONS: Our results suggest the underutilization of antibiotics in travelers with moderate or severe TD. Further studies are needed to systematically evaluate pre-travel instruction and traveler adherence to self-treatment guidelines, and the impact of suboptimal self-treatment on outcomes.
BACKGROUND:Infectious diarrhea is a common problem among travelers. Expert guidelines recommend the prompt use of antibiotics for self-treatment of moderate or severe travelers' diarrhea (TD). There is limited data on whether travelers follow these self-treatment guidelines. We evaluated the risk factors associated with TD, the use of TD self-treatment, and the risk of irritable bowel syndrome (IBS) during travel. METHODS: Department of Defense beneficiaries traveling outside the United States for ≤6.5 months were enrolled in a prospective cohort study. Participants received pre- and post-travel surveys, and could opt into a travel illness diary and follow-up surveys for symptoms of IBS. Standard definitions were used to assess for TD and IBS. Suboptimal self-treatment was defined as the use of antibiotics (with or without antidiarrheal agents) for mild TD, or the use of antidiarrheals alone or no self-treatment in cases of moderate or severe TD. RESULTS: Twenty-four percent of participants (270/1,120) met the criteria for TD. The highest incidence was recorded in Africa [8.6 cases/100 person-weeks, 95% confidence interval (CI): 6.7-10.5]. Two hundred and twelve participants with TD provided information regarding severity and self-treatment: 89 (42%) had mild TD and 123 (58%) had moderate or severe TD. Moderate or severe TD was independently associated with suboptimal self-treatment [OR 10.4 (95% CI: 4.92-22.0)]. Time to last unformed stool did not differ between optimal and suboptimal self-treatment. IBS occurred in 4.5% (7/154) of TD cases and in 3.1% (16/516) of cases without TD (p = 0.39). Among TD cases, a lower incidence of IBS was noted in participants who took antibiotics [4.8% (5/105) vs 2.2% (1/46)] in those who did not, but the difference did not reach statistical significance (p = 0.60). CONCLUSIONS: Our results suggest the underutilization of antibiotics in travelers with moderate or severe TD. Further studies are needed to systematically evaluate pre-travel instruction and traveler adherence to self-treatment guidelines, and the impact of suboptimal self-treatment on outcomes.
Authors: F von Sonnenburg; N Tornieporth; P Waiyaki; B Lowe; L F Peruski; H L DuPont; J J Mathewson; R Steffen Journal: Lancet Date: 2000-07-08 Impact factor: 79.321
Authors: Robert Steffen; Nadia Tornieporth; Sue-Ann Costa Clemens; Santanu Chatterjee; Ana-Maria Cavalcanti; Françoise Collard; Norbert De Clercq; Herbert L DuPont; Frank von Sonnenburg Journal: J Travel Med Date: 2004 Jul-Aug Impact factor: 8.490
Authors: Charles D Ericsson; Herbert L DuPont; Pablo C Okhuysen; Zhi-Dong Jiang; Margaret W DuPont Journal: J Travel Med Date: 2007 Sep-Oct Impact factor: 8.490
Authors: Parvathy Nair; Pablo C Okhuysen; Zhi-Dong Jiang; Lily G Carlin; Jaime Belkind-Gerson; Jose Flores; Mercedes Paredes; Herbert L DuPont Journal: J Travel Med Date: 2014-03-13 Impact factor: 8.490
Authors: Alexandra Ilnyckyj; Brinda Balachandra; Lawrence Elliott; Shurjeel Choudhri; Donald R Duerksen Journal: Am J Gastroenterol Date: 2003-03 Impact factor: 10.864
Authors: Rhett J Stoney; Pauline V Han; Elizabeth D Barnett; Mary E Wilson; Emily S Jentes; Christine M Benoit; William B MacLeod; Davidson H Hamer; Lin H Chen Journal: Am J Trop Med Hyg Date: 2017-06 Impact factor: 2.345
Authors: David P Ashley; Jamie Fraser; Heather Yun; Anjali Kunz; Mary Fairchok; David Tribble; Indrani Mitra; Mark D Johnson; Patrick W Hickey; Anuradha Ganesan; Robert G Deiss; Tahaniyat Lalani Journal: Am J Trop Med Hyg Date: 2019-05 Impact factor: 2.345
Authors: Tahaniyat Lalani; Jamie Fraser; Mark S Riddle; Ramiro L Gutierrez; Patrick W Hickey; David R Tribble Journal: Mil Med Date: 2019-11-01 Impact factor: 1.437
Authors: Mark S Riddle; Bradley A Connor; Nicholas J Beeching; Herbert L DuPont; Davidson H Hamer; Phyllis Kozarsky; Michael Libman; Robert Steffen; David Taylor; David R Tribble; Jordi Vila; Philipp Zanger; Charles D Ericsson Journal: J Travel Med Date: 2017-04-01 Impact factor: 8.490
Authors: Mary Carol Jennings; Drake H Tilley; Sarah-Blythe Ballard; Miguel Villanueva; Fernando Maldonado Costa; Martha Lopez; Hannah E Steinberg; C Giannina Luna; Rina Meza; Maria E Silva; Robert H Gilman; Mark P Simons; Ryan C Maves; Miguel M Cabada Journal: Am J Trop Med Hyg Date: 2017-02-06 Impact factor: 2.345
Authors: Robert Steffen; Zhi-Dong Jiang; Mónica L Gracias Garcia; Prithi Araujo; Michael Stiess; Tanju Nacak; Roland Greinwald; Herbert L DuPont Journal: J Travel Med Date: 2018-01-01 Impact factor: 8.490
Authors: Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco Journal: Foodborne Pathog Dis Date: 2019-10-07 Impact factor: 3.788